Clincosm LogoSign in Get a demo

Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
  • +2 more
  • Torrance, California
  • +25 more
Sep 28, 2023

COPD Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Benralizumab
  • Placebo
  • Montgomery, Alabama
  • +400 more
Jan 11, 2023

COPD Trial in Worldwide (Ensifentrine, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Alabaster, Alabama
  • +140 more
Nov 30, 2022

COPD Trial in Worldwide (Astegolimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Andalusia, Alabama
  • +170 more
Aug 4, 2022

Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via

Completed
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled NO delivered via INOpulse DS-C Device
  • Placebo delivered via INOpulse DS-C Device
  • Jasper, Alabama
  • +42 more
Jul 13, 2022

COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Dupilumab SAR231893
  • +4 more
  • Andalusia, Alabama
  • +286 more
May 11, 2022

COPD Trial in United States (Revefenacin, Tiotropium, Revefenacin Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Jasper, Alabama
  • +38 more
May 4, 2022

COPD Trial in Australia, New Zealand, United States (TV48108, Placebo)

Terminated
  • Chronic Obstructive Pulmonary Disease
  • Medford, Oregon
  • +6 more
Nov 6, 2021

COPD Trial in United States (Albuterol sulfate (ABS))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Albuterol sulfate (ABS)
  • Andalusia, Alabama
  • +39 more
Nov 5, 2021

COPD, COPD Trial in United States (CHF 5259, Placebo, Tiotropium Bromide 18 µg Inhalation Capsule)

Completed
Has Results
  • COPD
  • Chronic Obstructive Pulmonary Disease
  • CHF 5259
  • +2 more
  • Birmingham, Alabama
  • +111 more
May 20, 2021

COPD Trial in United States (Placebo, Test Product (tiotropium bromide inhalation powder), Reference Product (Spiriva®))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Placebo
  • +2 more
  • Andalusia, Alabama
  • +33 more
Mar 10, 2021

COPD Trial in United States (QAX028, Tiotropium, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Anaheim, California
  • +3 more
Dec 11, 2020

COPD Trial in United States (CHF 4226 pMDI, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • CHF 4226 pMDI
  • Placebo
  • DeLand, Florida
  • +4 more
Oct 28, 2019

COPD Trial in Worldwide (JNJ 49095397, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • JNJ 49095397
  • Placebo
  • Phoenix, Arizona
  • +48 more
Aug 19, 2019

COPD Trial in Worldwide (GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • GFF MDI (PT003)
  • +3 more
  • Andalusia, Alabama
  • +166 more
Jan 28, 2019

COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)

Completed
Has Results
  • COPD
  • +2 more
  • Aclidinium Bromide
  • Placebo
  • Birmingham, Alabama
  • +467 more
Nov 8, 2018

COPD Trial in Worldwide (Aclidinium bromide 400 µg/Formoterol Fumarate 12 µg (AB/FF 400/12 µg), Aclidinium bromide 400 µg (AB

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
  • +5 more
  • Gulf Shores, Alabama
  • +162 more
Nov 7, 2018

COPD Trial in United States (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BFF MDI 80/9.6 µg)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • BFF MDI 320/9.6 μg
  • +4 more
  • Rolling Hills Estates, California
  • +16 more
May 23, 2018

COPD Trial in United Kingdom, United States (EP-101 via nebulizer (eFlow®) 25 ug, EP-101 via nebulizer (eFlow®) 50 ug, EP-101

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • EP-101 via nebulizer (eFlow®) 25 ug
  • +6 more
  • Phoenix, Arizona
  • +10 more
May 8, 2018

COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Anaheim, California
  • +52 more
Mar 2, 2018

COPD Trial in United States (MP-376, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Haleyville, Alabama
  • +38 more
Jan 17, 2018

COPD Trial in United States (PT001 MDI, Tiotropium Bromide, PT001 Placebo MDI)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • PT001 MDI
  • +2 more
  • Fullerton, California
  • +9 more
Oct 10, 2017

COPD Trial in Worldwide (Lebrikizumab, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Birmingham, Alabama
  • +65 more
Sep 5, 2017

COPD Trial in United States (Aclidinium Bromide/Formoterol Fumarate, Formoterol Fumarate)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide/Formoterol Fumarate
  • Formoterol Fumarate
  • Birmingham, Alabama
  • +136 more
Apr 3, 2017

COPD Trial in United States (PT003, PT001, PT005)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Rancho Mirage, California
  • +12 more
Apr 26, 2017